ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,687.66
      1.31%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      06/07/20165:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/06/201612:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/16/20166:00PMGlobeNewswire Inc.Adamas Announces Two Data Presentations on ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) at the 20th Intern...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/10/20164:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/10/20164:07PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/10/20164:05PMGlobeNewswire Inc.Adamas Reports First Quarter 2016 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/06/20165:41PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/28/20167:00AMGlobeNewswire Inc.Adamas Announces Positive Top-line Results from its Phase 3 EASE LID 3 Trial of ADS-5102 for the Treatment of Levodopa-induce...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/27/20168:09PMGlobeNewswire Inc.Adamas to Host Conference Call and Webcast to Provide Company UpdateNASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/20/20165:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/19/20168:45PMGlobeNewswire Inc.Adamas Presents Positive Findings From the Phase 3 EASE LID Clinical Trial of ADS-5102 for the Treatment of Levodopa-induced ...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/18/20164:14PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/18/20164:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/14/20164:05PMGlobeNewswire Inc.Adamas Announces Data Update at the 68th American Academy of Neurology Annual MeetingNASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/24/20165:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/17/20164:05PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/08/20166:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/08/20166:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/08/20165:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/08/20165:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/23/20164:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/22/20164:05PMGlobeNewswire Inc.Adamas Pharmaceuticals to Present at Two Upcoming Healthcare ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/16/20166:08AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/12/20169:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/12/20168:50AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/11/20164:24PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/10/20168:45AMInvestorsHub NewsWireVarious Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan DrugNASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/10/20166:12AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/12/20164:05PMGlobeNewswire Inc.Adamas Pharmaceuticals Provides Review of 2015 and Projected Future MilestonesNASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/07/20164:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS